nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP4—blood plasma—acquired immunodeficiency syndrome	0.0248	0.14	CbGeAlD
Vildagliptin—DPP9—blood—acquired immunodeficiency syndrome	0.0237	0.134	CbGeAlD
Vildagliptin—DPP9—lung—acquired immunodeficiency syndrome	0.0208	0.117	CbGeAlD
Vildagliptin—DPP9—brain—acquired immunodeficiency syndrome	0.0147	0.0831	CbGeAlD
Vildagliptin—DPP9—lymph node—acquired immunodeficiency syndrome	0.0142	0.0803	CbGeAlD
Vildagliptin—DPP4—lymphoid tissue—acquired immunodeficiency syndrome	0.00965	0.0544	CbGeAlD
Vildagliptin—DPP4—digestive system—acquired immunodeficiency syndrome	0.00953	0.0538	CbGeAlD
Vildagliptin—DPP4—blood—acquired immunodeficiency syndrome	0.00908	0.0512	CbGeAlD
Vildagliptin—DPP4—bone marrow—acquired immunodeficiency syndrome	0.00878	0.0496	CbGeAlD
Vildagliptin—DPP4—vagina—acquired immunodeficiency syndrome	0.00841	0.0475	CbGeAlD
Vildagliptin—DPP4—lung—acquired immunodeficiency syndrome	0.00796	0.0449	CbGeAlD
Vildagliptin—DPP4—nervous system—acquired immunodeficiency syndrome	0.00737	0.0416	CbGeAlD
Vildagliptin—DPP4—central nervous system—acquired immunodeficiency syndrome	0.00709	0.04	CbGeAlD
Vildagliptin—DPP4—brain—acquired immunodeficiency syndrome	0.00563	0.0318	CbGeAlD
Vildagliptin—DPP4—lymph node—acquired immunodeficiency syndrome	0.00544	0.0307	CbGeAlD
Vildagliptin—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.00299	0.00363	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Indinavir—acquired immunodeficiency syndrome	0.00298	0.00362	CcSEcCtD
Vildagliptin—Infestation NOS—Efavirenz—acquired immunodeficiency syndrome	0.00298	0.00362	CcSEcCtD
Vildagliptin—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.00298	0.00362	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.00297	0.00361	CcSEcCtD
Vildagliptin—Weight increased—Delavirdine—acquired immunodeficiency syndrome	0.00291	0.00353	CcSEcCtD
Vildagliptin—Liver function test abnormal—Lamivudine—acquired immunodeficiency syndrome	0.0029	0.00352	CcSEcCtD
Vildagliptin—Pancreatitis—Ritonavir—acquired immunodeficiency syndrome	0.0029	0.00352	CcSEcCtD
Vildagliptin—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.00288	0.0035	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00286	0.00348	CcSEcCtD
Vildagliptin—Infection—Didanosine—acquired immunodeficiency syndrome	0.00285	0.00346	CcSEcCtD
Vildagliptin—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.00283	0.00344	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Efavirenz—acquired immunodeficiency syndrome	0.00282	0.00342	CcSEcCtD
Vildagliptin—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00281	0.00341	CcSEcCtD
Vildagliptin—Pancreatitis—Saquinavir—acquired immunodeficiency syndrome	0.00279	0.00339	CcSEcCtD
Vildagliptin—Connective tissue disorder—Indinavir—acquired immunodeficiency syndrome	0.00278	0.00338	CcSEcCtD
Vildagliptin—Chills—Zidovudine—acquired immunodeficiency syndrome	0.00273	0.00332	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00271	0.0033	CcSEcCtD
Vildagliptin—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00271	0.00329	CcSEcCtD
Vildagliptin—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.00269	0.00327	CcSEcCtD
Vildagliptin—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.00267	0.00325	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00267	0.00324	CcSEcCtD
Vildagliptin—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00266	0.00323	CcSEcCtD
Vildagliptin—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00265	0.00322	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00264	0.00321	CcSEcCtD
Vildagliptin—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.0032	CcSEcCtD
Vildagliptin—Connective tissue disorder—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.00319	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00261	0.00317	CcSEcCtD
Vildagliptin—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.00261	0.00317	CcSEcCtD
Vildagliptin—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.0026	0.00316	CcSEcCtD
Vildagliptin—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.00259	0.00315	CcSEcCtD
Vildagliptin—Weight increased—Saquinavir—acquired immunodeficiency syndrome	0.00259	0.00315	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00258	0.00314	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00313	CcSEcCtD
Vildagliptin—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00258	0.00313	CcSEcCtD
Vildagliptin—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.00256	0.00311	CcSEcCtD
Vildagliptin—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.00256	0.00311	CcSEcCtD
Vildagliptin—Chills—Indinavir—acquired immunodeficiency syndrome	0.00254	0.00309	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00254	0.00308	CcSEcCtD
Vildagliptin—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.00254	0.00308	CcSEcCtD
Vildagliptin—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.00254	0.00308	CcSEcCtD
Vildagliptin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.00307	CcSEcCtD
Vildagliptin—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.00252	0.00306	CcSEcCtD
Vildagliptin—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.0025	0.00304	CcSEcCtD
Vildagliptin—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00249	0.00303	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.00249	0.00303	CcSEcCtD
Vildagliptin—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.00248	0.00302	CcSEcCtD
Vildagliptin—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00246	0.00299	CcSEcCtD
Vildagliptin—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00245	0.00298	CcSEcCtD
Vildagliptin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00244	0.00296	CcSEcCtD
Vildagliptin—Infection—Abacavir—acquired immunodeficiency syndrome	0.00243	0.00296	CcSEcCtD
Vildagliptin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.00243	0.00295	CcSEcCtD
Vildagliptin—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00243	0.00295	CcSEcCtD
Vildagliptin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00242	0.00295	CcSEcCtD
Vildagliptin—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00242	0.00294	CcSEcCtD
Vildagliptin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00242	0.00294	CcSEcCtD
Vildagliptin—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00241	0.00293	CcSEcCtD
Vildagliptin—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.0024	0.00292	CcSEcCtD
Vildagliptin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.0024	0.00292	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.00292	CcSEcCtD
Vildagliptin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00238	0.00289	CcSEcCtD
Vildagliptin—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00237	0.00287	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00235	0.00285	CcSEcCtD
Vildagliptin—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00233	0.00283	CcSEcCtD
Vildagliptin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00233	0.00283	CcSEcCtD
Vildagliptin—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.00232	0.00283	CcSEcCtD
Vildagliptin—Tremor—Indinavir—acquired immunodeficiency syndrome	0.00231	0.0028	CcSEcCtD
Vildagliptin—Chills—Delavirdine—acquired immunodeficiency syndrome	0.0023	0.00279	CcSEcCtD
Vildagliptin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00279	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00278	CcSEcCtD
Vildagliptin—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00228	0.00277	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00227	0.00276	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00227	0.00275	CcSEcCtD
Vildagliptin—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00225	0.00274	CcSEcCtD
Vildagliptin—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00225	0.00274	CcSEcCtD
Vildagliptin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00225	0.00274	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00272	CcSEcCtD
Vildagliptin—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.00224	0.00272	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00223	0.00271	CcSEcCtD
Vildagliptin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00223	0.00271	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00222	0.0027	CcSEcCtD
Vildagliptin—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00222	0.0027	CcSEcCtD
Vildagliptin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00267	CcSEcCtD
Vildagliptin—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00218	0.00265	CcSEcCtD
Vildagliptin—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00217	0.00264	CcSEcCtD
Vildagliptin—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00216	0.00263	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00215	0.00262	CcSEcCtD
Vildagliptin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00215	0.00261	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00215	0.00261	CcSEcCtD
Vildagliptin—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00215	0.00261	CcSEcCtD
Vildagliptin—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00214	0.00261	CcSEcCtD
Vildagliptin—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00213	0.00259	CcSEcCtD
Vildagliptin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00213	0.00258	CcSEcCtD
Vildagliptin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00213	0.00258	CcSEcCtD
Vildagliptin—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00212	0.00258	CcSEcCtD
Vildagliptin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00212	0.00258	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00212	0.00257	CcSEcCtD
Vildagliptin—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00211	0.00257	CcSEcCtD
Vildagliptin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.0021	0.00255	CcSEcCtD
Vildagliptin—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.0021	0.00255	CcSEcCtD
Vildagliptin—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00209	0.00254	CcSEcCtD
Vildagliptin—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00209	0.00254	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00253	CcSEcCtD
Vildagliptin—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00207	0.00251	CcSEcCtD
Vildagliptin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.0025	CcSEcCtD
Vildagliptin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00206	0.0025	CcSEcCtD
Vildagliptin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00205	0.00249	CcSEcCtD
Vildagliptin—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.00248	CcSEcCtD
Vildagliptin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00247	CcSEcCtD
Vildagliptin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00247	CcSEcCtD
Vildagliptin—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00201	0.00244	CcSEcCtD
Vildagliptin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00241	CcSEcCtD
Vildagliptin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00198	0.00241	CcSEcCtD
Vildagliptin—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00198	0.00241	CcSEcCtD
Vildagliptin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00198	0.0024	CcSEcCtD
Vildagliptin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00197	0.0024	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00197	0.00239	CcSEcCtD
Vildagliptin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00197	0.00239	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00239	CcSEcCtD
Vildagliptin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00196	0.00238	CcSEcCtD
Vildagliptin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00237	CcSEcCtD
Vildagliptin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00195	0.00237	CcSEcCtD
Vildagliptin—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00195	0.00237	CcSEcCtD
Vildagliptin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00195	0.00237	CcSEcCtD
Vildagliptin—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00194	0.00236	CcSEcCtD
Vildagliptin—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00193	0.00234	CcSEcCtD
Vildagliptin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.0019	0.0023	CcSEcCtD
Vildagliptin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.0023	CcSEcCtD
Vildagliptin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00187	0.00227	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00187	0.00227	CcSEcCtD
Vildagliptin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00186	0.00227	CcSEcCtD
Vildagliptin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00186	0.00226	CcSEcCtD
Vildagliptin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.00226	CcSEcCtD
Vildagliptin—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00226	CcSEcCtD
Vildagliptin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00185	0.00225	CcSEcCtD
Vildagliptin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00185	0.00225	CcSEcCtD
Vildagliptin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00224	CcSEcCtD
Vildagliptin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00223	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00223	CcSEcCtD
Vildagliptin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00221	CcSEcCtD
Vildagliptin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00219	CcSEcCtD
Vildagliptin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00179	0.00218	CcSEcCtD
Vildagliptin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00179	0.00218	CcSEcCtD
Vildagliptin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00178	0.00217	CcSEcCtD
Vildagliptin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00177	0.00215	CcSEcCtD
Vildagliptin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00215	CcSEcCtD
Vildagliptin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00176	0.00214	CcSEcCtD
Vildagliptin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00176	0.00214	CcSEcCtD
Vildagliptin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00214	CcSEcCtD
Vildagliptin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00213	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00212	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00174	0.00211	CcSEcCtD
Vildagliptin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00173	0.00211	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.0021	CcSEcCtD
Vildagliptin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.0021	CcSEcCtD
Vildagliptin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00172	0.00209	CcSEcCtD
Vildagliptin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00209	CcSEcCtD
Vildagliptin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00207	CcSEcCtD
Vildagliptin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.0017	0.00207	CcSEcCtD
Vildagliptin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0017	0.00207	CcSEcCtD
Vildagliptin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00169	0.00205	CcSEcCtD
Vildagliptin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00204	CcSEcCtD
Vildagliptin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00204	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00204	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00201	CcSEcCtD
Vildagliptin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00165	0.002	CcSEcCtD
Vildagliptin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.002	CcSEcCtD
Vildagliptin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00164	0.002	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00164	0.00199	CcSEcCtD
Vildagliptin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00164	0.00199	CcSEcCtD
Vildagliptin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00198	CcSEcCtD
Vildagliptin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00197	CcSEcCtD
Vildagliptin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00197	CcSEcCtD
Vildagliptin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00162	0.00197	CcSEcCtD
Vildagliptin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00197	CcSEcCtD
Vildagliptin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00161	0.00196	CcSEcCtD
Vildagliptin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00161	0.00196	CcSEcCtD
Vildagliptin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.00195	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.00194	CcSEcCtD
Vildagliptin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00194	CcSEcCtD
Vildagliptin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00193	CcSEcCtD
Vildagliptin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00157	0.00191	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00157	0.00191	CcSEcCtD
Vildagliptin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00157	0.0019	CcSEcCtD
Vildagliptin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.0019	CcSEcCtD
Vildagliptin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00156	0.0019	CcSEcCtD
Vildagliptin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00156	0.00189	CcSEcCtD
Vildagliptin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00189	CcSEcCtD
Vildagliptin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00155	0.00188	CcSEcCtD
Vildagliptin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00188	CcSEcCtD
Vildagliptin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00153	0.00187	CcSEcCtD
Vildagliptin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.00186	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00186	CcSEcCtD
Vildagliptin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00153	0.00186	CcSEcCtD
Vildagliptin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00184	CcSEcCtD
Vildagliptin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00183	CcSEcCtD
Vildagliptin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.0015	0.00182	CcSEcCtD
Vildagliptin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00181	CcSEcCtD
Vildagliptin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00148	0.0018	CcSEcCtD
Vildagliptin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00148	0.0018	CcSEcCtD
Vildagliptin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00148	0.0018	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00147	0.00179	CcSEcCtD
Vildagliptin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00177	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00176	CcSEcCtD
Vildagliptin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00176	CcSEcCtD
Vildagliptin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00175	CcSEcCtD
Vildagliptin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00175	CcSEcCtD
Vildagliptin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00175	CcSEcCtD
Vildagliptin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00174	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00171	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.0014	0.0017	CcSEcCtD
Vildagliptin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00169	CcSEcCtD
Vildagliptin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00168	CcSEcCtD
Vildagliptin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00167	CcSEcCtD
Vildagliptin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00166	CcSEcCtD
Vildagliptin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00135	0.00165	CcSEcCtD
Vildagliptin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00162	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Vildagliptin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Vildagliptin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Vildagliptin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.0016	CcSEcCtD
Vildagliptin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00158	CcSEcCtD
Vildagliptin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00158	CcSEcCtD
Vildagliptin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Vildagliptin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Vildagliptin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00153	CcSEcCtD
Vildagliptin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00153	CcSEcCtD
Vildagliptin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00151	CcSEcCtD
Vildagliptin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00149	CcSEcCtD
Vildagliptin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00147	CcSEcCtD
Vildagliptin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00146	CcSEcCtD
Vildagliptin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Vildagliptin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Vildagliptin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00141	CcSEcCtD
Vildagliptin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.0014	CcSEcCtD
Vildagliptin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00138	CcSEcCtD
Vildagliptin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00137	CcSEcCtD
Vildagliptin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Vildagliptin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Vildagliptin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Vildagliptin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00131	CcSEcCtD
Vildagliptin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.0013	CcSEcCtD
Vildagliptin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00128	CcSEcCtD
Vildagliptin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00128	CcSEcCtD
Vildagliptin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Vildagliptin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00123	CcSEcCtD
Vildagliptin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000998	0.00121	CcSEcCtD
Vildagliptin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000967	0.00117	CcSEcCtD
Vildagliptin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000961	0.00117	CcSEcCtD
Vildagliptin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000917	0.00111	CcSEcCtD
